Collaboration Partners

Partnerships

We are partners in research networks and consortia granted by the Spanish and EU funding programmes in diverse areas of drug discovery and applied biotechnology.

pharmasea
bluegreen
microsmetics
paramet
ricet
ocean medicines
imind4

 

Collaborations

granada
SCIC2
pablo

We develop active collaborations with national and international organizations including academia, research institutes and private companies.

universidadsevilla
uni madrid
bcn
jaen
alcala
oviedo
salamanca
isciii3
ibs
ciberer
ceibiotic
ceu
cnio
vhio2
mac
reipi
ndpi
hki
ibis2
vib
pasteur
henry ford 4
sidney
dtu3
chicago
nice
mc master
cycleniumweb
abacweb
iden
descarga
eligochemweb

 

Memberships

sem
asebio
european biotec

We are corporate members of national & international scientific societies and biotech sector associations. 

sebbmm


Projects

TOPCAPI - Thoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients

Funded by: EUROPEAN COMMISSION - Horizon 2020 - NMBP-BIO-2016 - Proposal 720793-2 - Duration (months): 48

TOPCAPI will exploit the natural biosynthetic potential of actinomycetes as microbial cell factories to produce advanced pharmaceutical ingredients: a new anti-acne drug, in Phase II clinical trials, and three related drugs against multidrug resistant bacteria MRSA, in Phase III clinical trials.  For that purpose, two common microbial bacteria will be characterized using systems biology approaches, applying integrated data analysis to transcriptomics and metabolomics experiments, combined with predictive mathematical modelling to drive the rapid improvement of these microbial cell factories for industrial production of these drugs. At the same time, we will establish a toolbox for future engineering high value advanced pharmaceutical ingredients.

 


 

MARPIPE - Improving the flow in the pipeline of the next generation of marine biodiscovery scientists

Funded by: European Commission Horizon 2020 - MSCA-ITN-ETN, Ref: 721421; Duration: 48 months

MarPipe is a consortium of 11 partners (IBP-CNR, SZN, UiT, UNIABDN, GEOMAR, KULeuven, UCC, eCOAST, MEDINA, MicroDish, Italbiotec) based in 8 countries (I, N, UK, D, B, IRL, E, NL), including 3 from the non-academic sector. MarPipe aims at further development of antimicrobial and anticancer lead compounds originating from a previous EU project (PharmaSea), and will also explore the bioactivity of deep-sea samples (5000m) collected during the recent Eurofleet-2 project in the sub-Antarctic.

OCEAN MEDICINES - Stimulating innovation by means of cross-fertilisation of knowledge

Funded by: European Commission H2020-EU.1.3.3. - Project reference: 690944 - Duration: 01/12/ 2015 to 30/11/2019

Ocean Medicines, a network of academic, research centres and SMEs across Europe, aims to establish a network of collaboration and knowledge-exchange between industrial and academic partners to further develop lead compounds from marine microorganisms having anticancer or anti-infective effects that have already been identified by the consortium.

ocean medicines

 

http://cordis.europa.eu/project/rcn/198834_en.html

 

Determination of metabolomics profiles for the diagnostic of breast cancer

Funded by the Ministry of Economy and Competitiveness of the Governement of Spain. RETOS project Ref - RTC-2016-5674-1

Lead by ALHIA HEALTH, participants: ALTHIA HEALTH, MEDINA, FIBAO.

RETOALTHIA

 

 

MINCOMP

BLUE AND GREEN - Marine Biotechnology

Funding: European Union’s Horizon 2020 research and innovation programme under grant agreement No 692419.

BLUEandGREEN aims to increase the performance of CIIMAR in the area of Marine Biotechnology, and joins CIIMAR with four internationally-leading counterparts at the EU level: the University of Helsinki - Finland, the University of Bergen - Norway, GEOMAR, Helmholtz Centre for Ocean Research Kiel – Germany, and Fundación MEDINA - Spain.

bluegreen

logoeu22

 

ENABLE - European Gram Negative Antibacterial Engine

Funded by: Innovative Medicines Iniciative (IMI)- New Drugs for Bad Bugs ND4BB Duration: 2013-2018

emiepfia

http://www.imi.europa.eu

MICROSMETICS - Exploitation of microbial biodiversity for the discovery and development of novel cosmeceutical agents

Funded by: European Union FP7-PEOPLE-2013-IAPP under grant agreemet nº 612276 Duration: 2013-2017

micrsmeticsand co

http://www.microsmetics.eu

logoeu22

Impacto en salud pública de la dispersión de enterobacterias productoras de carbapenemasas en España: Caracterización molecular de las cepas circulantes

Funded by: under agreement nº PI12/0242 Duration: 2013-2015

isciiipj

http://www.isciii.es

PharmaSea - Value Flow in the Marine Biodiscovery Pipeline

Funded by: European Union FP7-KBBE-2012-6-singlestage under grant agreemet nº 312184 Duration: 2012-2015

pharma7th

http://www.pharma-sea.eu

 

ParaMet - An analysis of parasite metabolism-from metabolism to intervention

Funded by: European Union FP7-PEOPLE-2011-ITN under grant agreemet nº 290080 - 2012-2015

PARAMETEU

http://www.paramet.eu

COCULMICRO - Cocultivation of microorganisms as a strategy for discovery of new natural products with antimicrobial properties

Funded by: European Union FP7-PEOPLE-2011-CIG Marie Curie Support for Training & Career develoment of researchers under grant agreement nº PCIG09-GA-2011-293992 - 08/2011-07/2015

logoeu22

 

DOSYMNPS - Novel applications of diffusion NMR spectroscopy in microbial natural products research

Funded by: European Union FP7-PEOPLE-2011-CIG Marie Curie Support for Training & Career develoment of researchers under grant agreement nº PCIG09-GA-2011-293762 - 09/2011-08/2015

http://cordis.europa.eu/project/rcn/99978_en.html

logoeu22

Descubrimiento de nuevos antibicoticos mediante la combinación de dos estrategias: cultivo de bacterias no cultivadas previamente y muestreo de hábitats salinos de Andalucía

Funded by: Regional Government of Andalucía. Project in Scientific Excellence under grant agreement nº CTS-5859 - 2011-2013

JUNTA ANDALUCIA

http://www.juntadeandalucia.es

Descubrimiento y desarrollo de nuevos antibióticos frente a bacterias gram negativas multiresistentes y de fármacos potenciadores de la actividad de carpabenems

Funded by: Regional Government of Andalucía. Project in Scientific Excellence under grant agreement nº CVI-6909 - 2011-2013

JUNTAUGR

http://www.juntadeandalucia.es

Antibiotics against multiresistant Gram negative pathogens and potentiators of carbapenem activity

Funded by: Research In Health Sciences Program, Health Sciences Institute Carlos III under grant agreement nº PI10/00745 - 2011-2013

isciiipj

http://www.isciii.es

Use of zebrafish as experimental model: evaluation of mithocondrial disfunction and identification of neuroprotective compounds from microbial natural in collaboration with The University of Granada

Funded by: Regional Government of Andalucía. Project in Scientific Excellence under grant agreement nº CTS-5784

JUNTAUGR

http://www.juntadeandalucia.es

Equipamiento complementario de alto rendimiento para el aislamiento y caracterización de Productos Naturales Bioactivos

Funded by: Spanish Ministry of Science and Innovation under grant agreement INP-2011-0016-PCT-010000-ACT6 - 2011

ministeriocienciainov

http://www.mineco.gob.es/

Discovery and characterization of new antibiotics by culturing previously uncultured bacteria

Funded by: Spanish Ministry of Science and Innovation. Non-Oriented Basic Research Project under grant agreement nº SAF2010-15010 - 2011-2013

ministeriocienciainov

http://www.mineco.gob.es

Búsqueda de Nuevos Antibacterianos y Caractericación de la Librería de Productos Naturales de la Fundación MEDINA

Funded by: Ministerio de Ciencia e Innovación dentro de los Presupuestos Generales del Estado para el 2010 aplicación presupuestaria 21.03.463B.789.01 - 2010

ministeriocienciainov

http://www.mineco.gob.es

Discovery and development of pharmaceuticals efficacious for amyotrophic lateral sclerosis (Lou Gerhig´s Disease)

Funded by: Ministry of Science and Innovation under grant agreement: PPT-300000-2009-2011

ministeriocienciainov

http://www.idi.mineco.gob.es

AntiFun: The cell wall as a target to improve antifungal therapy against Aspergillosis

Funded by: ERA-NET: Pathogenomics (7th FP) - 2009-201

eraneteu

https://www.pathogenomics-era.net

CONSOLIDER-INGENIO 2010: Discovery of novel antimicrobials from the Metagenome of the Iberian Peninsula

Funded by: Spanish Ministry of Science and Innovation - 2008-2012

ministeriocienciainov

http://www.idi.mineco.gob.es/